Current Assets
Cash & Equivalents
STERIS Cash & Equivalents increased by 32.7% to $423.70M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 173.0%, from $155.20M to $423.70M. Over 4 years (FY 2021 to FY 2025), Cash & Equivalents shows a downward trend with a -6.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryLiquidity
SignalHigher is better
VolatilityModerate
First reportedQ4 2013
Last reportedQ1 2026
How to read this metric
Higher levels indicate strong liquidity and financial flexibility; lower levels may signal potential cash flow issues.
Detailed definition
This represents the most liquid assets held by the company, including cash on hand, demand deposits, and short-term inve...
Peer comparison
A universal metric for assessing a company's immediate financial health.
Metric ID:
cash_and_equivalentsHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $534.77M | $383.49M | $359.09M | $348.32M | $316.33M | $258.26M | $259.37M | $208.36M | $208.61M | $213.76M | $195.59M | $207.00M | $198.30M | $172.20M | $155.20M | $171.70M | $279.70M | $319.20M | $423.70M |
| QoQ Change | — | -28.3% | -6.4% | -3.0% | -9.2% | -18.4% | +0.4% | -19.7% | +0.1% | +2.5% | -8.5% | +5.8% | -4.2% | -13.2% | -9.9% | +10.6% | +62.9% | +14.1% | +32.7% |
| YoY Change | — | — | — | — | -40.8% | -32.7% | -27.8% | -40.2% | -34.1% | -17.2% | -24.6% | -0.7% | -4.9% | -19.4% | -20.6% | -17.1% | +41.0% | +85.4% | +173.0% |
Range$155.20M – $534.77M
CAGR-5.0%
Avg YoY Growth+1.3%
Median YoY Growth-19.4%
Current Streak4 quarters growth
Cash & Equivalents at Other Companies
Frequently Asked Questions
- What is STERIS's cash & equivalents?
- STERIS (STE) reported cash & equivalents of $423.70M in Q4 2025.
- How has STERIS's cash & equivalents changed year-over-year?
- STERIS's cash & equivalents increased by 173.0% year-over-year, from $155.20M to $423.70M.
- What is the long-term trend for STERIS's cash & equivalents?
- Over 4 years (2021 to 2025), STERIS's cash & equivalents has grown at a -6.1% compound annual growth rate (CAGR), from $220.53M to $171.70M.
- What does cash & equivalents mean?
- Cash and highly liquid assets that can be converted to cash within 90 days.